Alzheimer’s disease is not “brain aging”: neuropathological, genetic, and epidemiological human studies
- 24 April 2011
- journal article
- review article
- Published by Springer Science and Business Media LLC in Acta Neuropathologica
- Vol. 121 (5), 571-587
- https://doi.org/10.1007/s00401-011-0826-y
Abstract
Human studies are reviewed concerning whether “aging”-related mechanisms contribute to Alzheimer’s disease (AD) pathogenesis. AD is defined by specific neuropathology: neuritic amyloid plaques and neocortical neurofibrillary tangles. AD pathology is driven by genetic factors related not to aging per se, but instead to the amyloid precursor protein (APP). In contrast to genes involved in APP-related mechanisms, there is no firm connection between genes implicated in human “accelerated aging” diseases (progerias) and AD. The epidemiology of AD in advanced age is highly relevant but deceptively challenging to address given the low autopsy rates in most countries. In extreme old age, brain diseases other than AD approximate AD prevalence while the impact of AD pathology appears to peak by age 95 and decline thereafter. Many distinct brain diseases other than AD afflict older human brains and contribute to cognitive impairment. Additional prevalent pathologies include cerebrovascular disease and hippocampal sclerosis, both high-morbidity brain diseases that appear to peak in incidence later than AD chronologically. Because of these common brain diseases of extreme old age, the epidemiology differs between clinical “dementia” and the subset of dementia cases with AD pathology. Additional aging-associated mechanisms for cognitive decline such as diabetes and synapse loss have been linked to AD and these hypotheses are discussed. Criteria are proposed to define an “aging-linked” disease, and AD fails all of these criteria. In conclusion, it may be most fruitful to focus attention on specific pathways involved in AD rather than attributing it to an inevitable consequence of aging.Keywords
This publication has 231 references indexed in Scilit:
- Insulin Resistance and Alzheimer-like Reductions in Regional Cerebral Glucose Metabolism for Cognitively Normal Adults With Prediabetes or Early Type 2 DiabetesArchives of Neurology, 2011
- Investigation of 15 of the top candidate genes for late-onset Alzheimer’s diseaseHuman Genetics, 2010
- Meta-analysis Confirms CR1, CLU, and PICALM as Alzheimer Disease Risk Loci and Reveals Interactions With APOE GenotypesArchives of Neurology, 2010
- Genetic Variation and Neuroimaging Measures in Alzheimer DiseaseArchives of Neurology, 2010
- Genome-wide Analysis of Genetic Loci Associated With Alzheimer DiseaseJAMA, 2010
- Dementia incidence continues to increase with age in the oldest old: The 90+ studyAnnals of Neurology, 2010
- The Role of Metabolic Disorders in Alzheimer Disease and Vascular DementiaArchives of Neurology, 2009
- Different Patterns of Cerebral Injury in Dementia With or Without DiabetesArchives of Neurology, 2009
- Role of the Neuropathology of Alzheimer Disease in Dementia in the Oldest-OldArchives of Neurology, 2008
- Oxidative Stress and AgingPublished by Springer Science and Business Media LLC ,2003